Glycogen storage disease, unspecified. A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement. An inherited metabolic...
An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues. Any of a group of metabolic disorders characterized by excessive storage of glycogen.
lipid storage disorders ( E75.-) amyloidosis ( E85.-) Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
ICD-10 code R68. 89 for Other general symptoms and signs is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 code E88. 01 for Alpha-1-antitrypsin deficiency is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
ICD-10 code: E88. 9 Metabolic disorder, unspecified.
Glycogen storage disease (GSD) is a rare metabolic disorder where the body is not able to properly store or break down glycogen, a form of sugar or glucose. GSD affects the liver, muscles and other areas of the body, depending on the specific type.
What Are the Symptoms of AAT Deficiency?Shortness of breath.Excessive cough with phlegm/sputum production.Wheezing.Decrease in exercise capacity and a persistent low energy state or tiredness.Chest pain that increases when breathing in.
ICD-10 code K75. 81 for Nonalcoholic steatohepatitis (NASH) is a medical classification as listed by WHO under the range - Diseases of the digestive system .
10 for Atherosclerotic heart disease of native coronary artery without angina pectoris is a medical classification as listed by WHO under the range - Diseases of the circulatory system .
ICD-10 code R73. 01 for Impaired fasting glucose is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
E88. 9 - Metabolic disorder, unspecified | ICD-10-CM.
Types of Glycogen Storage Disease They include: Type I (Von Gierke disease) – this is the most common type of glycogen storage disease, and accounts for 90% of all glycogen storage disease cases. Type II (Pompe's disease, acid maltase deficiency) Type III (Cori's disease)
A glycogen storage disorder occurs in about one in 20,000 to 25,000 babies. The most common types of GSD are types I, II, III, and IV, with type I being the most common. It is believed that nearly 90% of all patients with GSD have types I through IV. About 25% of patients with GSD are thought to have type I.
GSD-III is a genetic disorder characterized by variable liver, cardiac muscle and skeletal muscle abnormalities. Symptoms are associated with abnormalities in the AGL gene, causing deficiency of the glycogen debranching enzyme. GSD-III is inherited as an autosomal recessive trait.
Alpha-1 antitrypsin deficiency (AAT deficiency) is an inherited condition that raises your risk for lung and liver disease. Alpha-1 antitrypsin (AAT) is a protein that protects the lungs. The liver makes it. If the AAT proteins aren't the right shape, they get stuck in the liver cells and can't reach the lungs.
An Alpha-1 carrier is a person who has one normal alpha-1 gene (M) and one defective alpha-1 gene (usually Z or S). Being a carrier is very common. It is believed that over 19 million people in the United States are carriers. Most Alpha-1 carriers are MZ or MS.
The only specific therapy for alpha-1 antitrypsin deficiency (AATD) is augmentation therapy. During this therapy, preparations of alpha-1 antitrypsin protein that have been isolated from pooled blood of healthy donors are given by weekly intravenous infusion.
A deficiency of A1AT allows substances that break down proteins (so-called proteolytic enzymes) to attack various tissues of the body. The attack results in destructive changes in the lungs (emphysema) and may also affect the liver and skin.
Glycogen storage disease type V (GSD-V) is a metabolic disorder, more specifically a glycogen storage disease, caused by a deficiency of myophosphorylase. Its incidence is reported as 1 in 100,000, approximately the same as glycogen storage disease type I.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code E74.00 and a single ICD9 code, 271.0 is an approximate match for comparison and conversion purposes.
The 2021 edition of ICD-10-CM E74.0 became effective on October 1, 2020.
An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues. Any of a group of metabolic disorders characterized by excessive storage of glycogen. Code History.